This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Novartis Ag. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Antoine De Weck: Innovator in Cancer Treatment
Introduction
Antoine De Weck is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work focuses on personalized therapies that aim to improve patient outcomes in the fight against cancer.
Latest Patents
Antoine De Weck holds a patent for "Compositions and methods to treat cancer." This patent provides novel personalized therapies, kits, transmittable forms of information, and methods for use in treating patients with cancer. The therapies are designed for cancers that are amenable to therapeutic treatment with an inhibitor. The patent also includes kits, methods of screening for candidate inhibitors, and associated methods of treatment.
Career Highlights
Throughout his career, Antoine has been associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking advancements in cancer therapies.
Collaborations
Antoine has worked alongside notable colleagues such as Eric Billy and Javad Golji. Their combined expertise has fostered an environment of innovation and collaboration, leading to significant advancements in cancer treatment methodologies.
Conclusion
Antoine De Weck's contributions to cancer treatment through his innovative patent and collaborations highlight his commitment to improving patient care. His work continues to inspire advancements in personalized medicine and cancer therapies.